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Background: Pattern recognition receptors of the immune system have key roles in the regulation of pathways
after the recognition of microbial- and danger-associated molecular patterns in vertebrates. Members of NOD-like
receptor (NLR) family typically function intracellularly. The NOD-like receptor family CARD domain containing 5
(NLRC5) is the largest member of this family that also contains the largest number of leucine-rich repeats (LRRs).
Due to the lack of crystal structures of full-length NLRs, projects have been initiated with the aim to model certain
or all members of the family, but systematic studies did not model the full-length NLRC5 due to its unique domain
architecture.
Our aim was to analyze the LRR sequences of NLRC5 and some NLRC5-related proteins and to build a model for
the full-length human NLRC5 by homology modeling.
Results: LRR sequences of NLRC5 were aligned and were compared with the consensus pattern of ribonuclease
inhibitor protein (RI)-like LRR subfamily. Two types of alternating consensus patterns previously identified for RI
repeats were also found in NLRC5. A homology model for full-length human NLRC5 was prepared and, besides the
closed conformation of monomeric NLRC5, a heptameric platform was also modeled for the opened
conformational NLRC5 monomers.
Conclusions: Identification of consensus patterns of leucine-rich repeat sequences helped to identify LRRs in
NLRC5 and to predict their number and position within the protein. In spite of the lack of fully adequate template
structures, the presence of an untypical CARD domain and unusually high number of LRRs in NLRC5, we were able
to construct a homology model for both the monomeric and homo-heptameric full-length human NLRC5 protein.
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The innate immune system in vertebrates has pattern
recognition receptor (PRR) families that trigger inflamma-
tory pathways in response to microbes or danger signals.
Both the secreted PRRs released into the extracellular space
as well as the membrane-associated PRRs, like Toll-like re-
ceptors (TLRs), are responsible for the recognition of extra-
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reproduction in any medium, provided the orwhile the PRRs located in the cytosol, like NOD-like
receptors (NLRs), recognize PAMPs intracellularly [1].
In humans, the NLR family contains 22 members having
in common the presence of a central NACHT domain
(present in NAIP, CIITA, HET-E, and TP1) and a C-
terminal leucine-rich repeat (LRR) receptor domain with
various lengths [2–5] (Figure 1). Classification of NLR pro-
tein family members is based on the type of the N-terminal
effector domains that defines the subfamilies of the NLR
family. For example, the NLRC proteins contain CARD
domain (caspase activation and recruitment domain), the
NLRP proteins contain PYRIN domain, while the NAIP
protein (neuronal apoptosis inhibitory protein, also referred
as NLRB1) has BIR (baculovirus inhibitor of apoptosis
protein repeat) domain [4]. The NLRC subfamily containsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Schematic representation of the domain structures of NLRC5 and NLRC5-related proteins. Upper lines in grey color: Domain
architecture of RI [PDB: 1Z7X]; NLRC1 [UniProtKB: Q9Y239]; NLRC2 [UniProtKB: Q9HC29]; NLRC3 [UniProtKB: Q7RTR2]; NLRC5 [UniProtKB: Q86WI3]
and C2TA [UniProtKB: P33076] proteins based on data available in the PDB and the UniProtKB databases at 22th January 2013. Under lines:
Domain architecture of NLRC5 and NLRC5-related proteins; the CARD and NACHT domains are indicated based on the database data and the
putative LRRs are indicated based on the results of the sequence alignment and consensus sequences. uCARD domain of NLRC5 is not shown,
because this domain is not indicated in the UniProt database due to its untypical nature. Domain and color legend: CARD - green, NACHT - red,
LRR – magenta. Typical consensus sequences of LRRs of RI (type A and B) and NLRC5 (type 1 and 2) of NLRC5 proteins and total number of LRRs
are indicated. The LRRs of NLRC5 which did not fit to the consensus pattern and length of RI-like LRR sequences are indicated with brighter
magenta color.
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domain containing protein 1, also referred as NOD1) and
NLRC2 (NOD2) possess one and two CARD domains,
respectively [4]. Though the CARD domain of NLRC3
(NOD4), C2TA (MHC class II transactivator protein,
also referred as CIITA or NLRA) and NLRC5 (NOD-like
receptor family CARD domain containing 5) is well
conserved in the mammalian orthologs [6], they show
low sequence similarity to the „typical” CARD domains.
Therefore they are classified into an untypical CARD
domain-containing subfamily of NLRs [4,7]. The untypical
CARD domain of NLRC5 is referred in this paper as
uCARD domain.
Based on the alignments of N- and C-terminal domain
sequences [6,8] the NLRC1, NLRC2, NLRC3 and C2TA
proteins of NLR protein family are the most closely
related to NLRC5. Alignment of the N-terminal effector
domains, the NACHT and LRR domains of NLRs showed
that C2TA protein shows the highest similarity to NLRC5
among the NLRC5-related proteins [4,6,8].NLRC5 is the largest family member of NLR family,
containing 1866 amino acid residues that results in 204
kDa predicted molecular weight [6]. Recent intensive
studies of this receptor revealed controversial roles for
this protein in both the innate and adaptive immune
responses.
In the domain architecture of NLRC5 the uCARD
domain is followed by NACHT, winged helix (WH),
superhelical (SH) and LRR domains [4]. The NACHT
domain is also known as nucleotide-binding domain
(NBD) or nucleotide-binding oligomerization domain
(NOD) and has an important role in the oligomerization
of NLRs, while the signaling effector uCARD domain is
predicted to be responsible for the interactions with the
adaptor proteins and for the activation of downstream
signaling [7]. Furthermore, it also has a key role in the
nuclear import since it contains the nuclear localization
signal (Lys121-Arg122-Arg132-Arg133-Lys134 in NLRC5
numbering) [5]. Most NLR protein family members con-
tain highly conserved residues in their WH domain, while
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currently unknown [4]. The C-terminal end of the NLRC5
contains LRRs that are typically 20–30 residue-long, rich
in leucine and contain consensus sequence motifs [9,10].
The hydrophobic residues are located in the inner part of
the LRR structural motif, while the hydrophilic residues
are exposed to the outer side of the repeats [10]. Im-
portantly, LRR-containing proteins differ in the number
of consecutive LRRs. LRR structures generally adopt a
“horseshoe” shape, in which the β-sheets of LRRs are on
the concave side and the helical elements are on the
convex side of the curved shape [9,10]. LRR domains
are thought to be responsible for the interactions with
ligands; however, the structural basis of specific molecule
recognition is not known [4]. The ribonuclease inhibitor
(RI) protein of Sus scrofa was the first LRR-containing
protein of which crystal structure was solved, providing an
insight into the structure of LRRs [11]. Despite the large
number of currently available crystal structures of LRR-
containing proteins [10], there is no available structural
data for full-length NLRs. While NMR or X-ray crystallo-
graphic structures of CARD or PYRIN domains of NLRC
or NLRP subfamily members are available, only short
regions of LRR sections of NLRs have been solved up to
now. The lack of structural data of NLRC5 initiated both
individual [12] and systematic studies [4,8] to generate
homology models. A previous systematic study hadn’t
prepared a homology model for NLRC5, noting that its
LRR domain appeared to be extremely large compared
to other LRR-containing proteins and the potential
template structures were found to be too small for hom-
ology modeling [8]. Therefore, the goal of our study
presented here was to predict the structure of both the
monomeric and the heptameric form of the full-length
human NLRC5 protein.
Methods
Databases and sequence alignments
Structural data were downloaded from Protein Data Bank
[13] while protein sequences and sequence annotation
data were derived from UniProt database [14]. Multiple
sequence alignments were performed using Clustal W
(1.83) and Clustal X (2.0.12) programs [15]. The LRRML
conformational LRR database (v0.6) [16], the LRRfinder2.0
webserver [17] and the LRR Conservation Mapping
Program [18] were used for the analyses of LRRs of NLRC5
protein.
Molecular modeling
Secondary structure predictions were performed using
the PredictProtein server [19]. Modeller 7v7 software was
used to prepare the homology models [20]. Molecular
dynamics calculations were performed by Sybyl program
package (Tripos Inc., St. Louis, MO, USA) using thefollowing parameters: AMBER7_FF99 force field, 1 fs
step size, 6 Å non-bonded cutoff, dielectric constant
was set to 4 and only the SH-LRR linker region of human
NLRC5 (Thr653-Gln687) was allowed to move. The mol-
ecule was gradually cooled from 300 to 10 K temperature
(temperature was set to 300, 250, 200, 150, 100 and 10 K
in the consecutive steps) and 1000 fs-long runs were
performed on every temperature value. Energy minimiza-
tions were performed by Sybyl without any fixed atoms
using the following parameters: AMBER7_FF99 force
field, 100–100 Powell iterations were applied using 6, 7
and 8 Å non-bonded cutoff values in the consecutive steps
and the dielectric constant was set to 4, 3 and 1, respect-
ively, followed by further 10.000 iterations using the pa-
rameters of the last previous run. Calculations and
molecular visualizations of the structural models were
performed using the Sybyl program package run on Silicon
Graphics Fuel workstations (Silicon Graphics International,
Fremont, CA, USA). POLYVIEW-3D (available at: http://
polyview.cchmc.org/polyview3d.html) was used to prepare
surface representation [21].
Results and discussion
Sequence alignment of NLRC5 and NLRC5-related
proteins
Previously published phylogenetic analyses were used to
identify the most closely related NLR proteins from which
the C2TA showed the highest sequence similarity to
NLRC5 [6,8]. Using structural and sequence data available
in databases, first we compared the domain organization
of the RI, C2TA, NLRC1, NLRC2, NLRC3 and NLRC5
proteins (Figure 1). Our result confirmed that NLRC5
shows a tripartite domain structure and was predicted to
consist of an N-terminal uCARD domain followed by the
NACHT domain, and the C-terminal part of the protein
contains LRRs [22]. The domain organization of NLRC1,
NLRC2, NLRC3 and NLRC5 proteins is very similar, but
while NLRC1 contains one and NLRC2 contains two
typical CARD domains, the NLRC3 and NLRC5 proteins
contain an untypical CARD domain [4].
To find consensus patterns in the sequences of leucine-
rich repeats we analyzed the amino acid sequences of RI,
C2TA, NLRC1, NLRC2, NLRC3 and NLRC5 proteins.
Sequence alignment was performed using the sequences
of putative LRRs of NLRC5 and NLRC5-related proteins
of different mammalian origin (human, mouse, horse,
bovine, pig, dog, rat or rhesus macaque) (Figure 2).
Leucine-rich repeats of LRR-containing proteins belong-
ing to RI-like subfamily are typically 28–29 residues long,
having α-helical conformation in their convex side and
show a high degree of curvature [9,10]. Our result from
sequence alignment and LRRML Conformational LRR
XML-Database analysis [16] showed that the LRRs of
NLRC5 and RI, C2TA, NLRC1, NLRC2 and NLRC3
Figure 2 The consensus sequences of putative C-terminal LRRs of NLRC5 and NLRC5-related proteins. Conserved residues are
marked by pink background and „X” represents any residue. Synonymous amino acids: L, I and V; S and T; E, D, Q and N; R and K. Most
frequent amino acids are shown within or under the consensus lines. Two typical types of LRRs are represented by A and B in case of RI and
by 1 and 2 in case of NLRC5. aConsensus pattern of LRR proteins belonging to RI-like subfamily based on Bella et al. [10]. „o” represents a
nonpolar residue, „-” represents a possible insertion site, g represents Gly residue identical or conservatively substituted in its positions in
more than 30% of sequences.
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long). Furthermore, we found that the consensus se-
quences of LRRs correspond well to the consensus pattern
of RI-like LRR subfamily (Figure 2) classified by Kajava and
Kobe [9,23]. To further identify the LRR motifs, a second-
ary structure prediction of the full-length human NLRC5
protein was also performed using the PredictProtein ser-
ver (see Additional file 1). Based on these results we deter-
mined the consensus sequences of LRRs (Figure 2) and 33
LRRs of NLRC5 were found to fit the consensus pattern
and length of RI-like LRR sequences (Figure 1). Both
the number of LRRs and their boundaries obtained in
this way differed from the data available in the databases
(Figure 1).
Human NLRC5 gene contains 49 exons from which 43
(from exon 7 to exon 49), being part of the transcript of
the coding sequence [Ensembl: ENST00000262510], were
analyzed. We observed that exons start at position 6 of
the previously showed consensus sequence of LRRs. Out
of the 43 exons analyzed, seven (exons 11, 12, 16, 17, 21,
26 and 30) were found to be too short and/or did not fit
the consensus pattern. These findings were confirmed
by the analysis using the LRR Conservation Mapping
Program [18], therefore the exon structure analysis pre-
dicted the presence of 36 typical LRRs in NLRC5.
In the absence of crystal structures the number and
individual length of LRRs in NLRC5 can only be predicted
with sequence annotation methods that are imprecise
[10]. Therefore, NLRC5 was predicted previously tocontain 20 LRRs [22], more than 20 LRRs [24], 26 LRRs
(http://www.uniprot.org), 27 LRRs [6] or 43 LRRs [8] in
different studies.
To gain more insight to LRRs we have also utilized
other bioinformatical tools: the LRRfinder2.0 webserver
for the prediction of leucine-rich repeats [17], the LRRML
Conformational LRR XML-Database [16] and the LRR
Conservation Mapping Program [18]. LRRfinder2.0 identi-
fied the lowest number of LRRs in NLRC5 which showed
the typical length of RI-like leucine-rich repeats. On
the other hand, the LRRML Conformational LRR XML-
Database was apparently more suitable to identify consen-
sus patterns in the LRRs, and the results we obtained
by the recently developed LRR Conservation Mapping
Program were in agreement with the results of exon
analysis, that we described above.
In spite of the use of multiple approaches in our study,
the exact number of LRRs in NLRC5 is still uncertain
and is likely between 33 and 43.
To predict the presence of unstructured regions, the
sequence of NLRC5 [UniProtKB: Q86WI3] was analyzed
by using the IUPred web server [25]. We found that
Ala822-Ser842 and Gly953-Ser962 regions of the LRR
domain could be short disordered regions. Interestingly,
these regions are encoded by the parts of exons 11, 12, 16
and 17, which were excluded as LRRs from the sequence
alignment due to their short length and lack of consensus
pattern. Although, alignment by the ANCHOR web server
[26] did not predict disordered binding regions for the
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these short disordered regions could be responsible for
the interactions with the ligands of NLRC5. However,
experimentally determined structural data are required to
verify the proposed disordered nature of these regions, as
well as the true number, length and boundaries of LRRs.
With further analysis of the LRR consensus patterns
we identified two types of consensus sequences (type 1
and 2) in NLRC5 (Figure 2). It was shown that these
consensus sequences alternate in the consecutive LRRs
as it was found previously for type A and B consensus
sequences of porcine ribonuclease inhibitor protein [27]
(Figure 1).
Several extracellular LRR proteins were reported to
contain N- and C-terminal capping motifs where
disulphide-bonds stabilize and protect the structure
[10]. Our sequence alignment resulted in the identifi-
cation of four cysteine-rich regions within the LRRFigure 3 LRRs of human NLRC5 and RI proteins. LRR domains are show
of human NLRC5 (Ile688-Thr1866) (A,B) and the crystal structure of human
(lower part) are represented. Color codes: α-helix: red, β-sheet: yellow, loopdomain. The Cys648-Cys698 cysteine-rich region showing
the Cx23Cx5Cx6Cx12C pattern is located at the N-terminal
end of the LRR domain and possibly corresponds to an
N-terminal capping motif of the LRR domain of NLRC5.
The C-terminal LRR repeat of NLRC5 was found to be
longer than the internal repeats (36 amino acid residue
long) based on the exon analysis, and similarly to the 34
amino acid residue long C-terminal capping motif of RI
protein [27] it possibly corresponds to the C-terminal
capping repeat in NLRC5.
While the TLR capping motifs are well studied [28],
there is no detailed information about the NLR capping
motifs due to the restricted number of structural data
for NLRs. Therefore, the cysteine-rich regions of human
NLRC5 were not further investigated in this work. Deeper
structural insight into the LRRs of NLR family members is
needed to verify both the structure and the function of
these cysteine-rich regions in NLRC5.n by ribbon/tube representation both in case of the homology model
RI (Ser1-Ser460) [PDB: 1Z7X] (C,D). Side (upper part) and top views
: cyan.
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Modeling of the LRR domain of human NLRC5 protein
Based on the X-ray structure of human ribonuclease in-
hibitor [PDB: 1Z7X] [29] we have built a model for the
LRR domain of human NLRC5 (Ile688-Thr1866) by
homology modeling (Figure 3A and 3B) using Modeller
7v7 software (see Additional file 2 and Additional file 3).
We have chosen to build up 43 LRRs, the largest num-
ber so far predicted, in correspondence with the study of
Istomin and coworkers [8] and in agreement with the
results of PredictProtein analysis (see Additional file 1).
Secondary structure prediction assigned α-helices or
β-sheets with slightly lower probability for the LRRs
encoded by the shorter exons (exons 11, 12, 16, 17, 21, 26
and 30 exons). However, our prediction did not suggest
extended unstructured regions within the LRR domain or
between the consecutive LRRs. In our model the shorter
LRRs were predicted to contain shorter α-helices in their
convex side compared to the longer continuous α-helices
of other LRRs or were predicted to contain shorter
loops. Our model suggests that the shorter LRRs do
not interrupt the curved shape of the LRR domain of
NLRC5, similarly to the model of Neerincx and his
coworkers [12] where the helical conformation of LRR
domain is also continuous.
The LRR domain was suggested to adopt a large helical
conformation in which the leucine-rich repeats form twoFigure 4 N-terminal domains of monomeric human NLRC5 protein. Pr
states are shown by ribbon representation. Domain and color codes in the
NACHT: blue, AxP: green, WH: orange, SH: red.full circles (Figure 3A and 3B) and does not have the pre-
viously proposed planar circular shape with large radius
[8]. Our model suggests that the LRR domain of hu-
man NLRC5 does not consist of more connected circu-
lar parts and adopts a continuous LRR helix shape formed
by two full LRR circles (Figure 3A and 3B) instead of the
presence of only one LRR circle [12].
Both N- and C-terminal cap regions are well-studied
in the case of LRR-containing proteins [10] and in TLRs
[28], while there is only limited information about the
capping motifs of NLRs due to the lack of crystal structures
and extended sequence alignments on capping motifs of
NLR family members.
The domain positioning of human NLRC5 protein was
predicted based on the structure of Apaf-1 protein (Apop-
totic Protease-Activating factor 1) which is distantly
related to NOD-like receptors [4]. Apaf-1 was found
previously to be a useful template to model the structure
of NLRC5 [12], as it is a homolog of NLRC5. Structure of
Apaf-1 have already been solved and was found to share
the common domain organization with NLR protein
family members [4]. Both a closed and an opened con-
formational structure of NLRC5 were predicted, there-
fore, two different template structures were used to
predict the structure of the N-terminal domains of NLRC5
protein by homology modeling (see Additional file 2 and
Additional file 3).edicted conformation of closed (A) and opened (B) conformational
homology model of human NLRC5 (Met1-Ala687): uCARD: cyan,
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conformational human NLRC5 protein
Based on the crystal structure of Apaf-1 protein we have
predicted a closed conformation of monomeric human
NLRC5 (Met1-Ala652) (Figure 4A) using Modeller 7v7
software (see Additional file 2 and Additional file 3). The
completion of the 1st, 3rd, 6th and 7th α-helices of Apaf-1
protein [PDB: 1Z6T] [30] was needed before homology
modeling. Biopolymer module of Sybyl was used to
complete these α-helices of the Apaf-1 which are part
of the uCARD domain of human NLRC5.
The small helical domain (Pro370-Pro453) of human
NLRC5 (referred here as AxP domain) is located next
to the NACHT domain and contains the conserved
Ala404-Val405-Pro406 structural motif. The AxP domain
of NLRC5 corresponds to the small helical domain (HD1)
of Apaf-1 [30] and the AxP signature corresponds to the
conserved GxP structural motif of Apaf-1. Most members
of NLR family contain this structural motif where only
the proline residue interacting with bound ATP is highly
conserved [4]. The functionally important regions of Apaf-
1 superimpose well with the same regions in the predicted
structure of human NLRC5: Walker A motif responsible
for nucleotide triphosphate binding (Gly228-Thr235
using NLRC5 numbering) (GKAGMGKT), Walker B
motif responsible for nucleotide triphosphate hydrolysisFigure 5 Molecular model for the monomeric full-length human NLRC
monomeric full-length human NLRC5 protein in its opened conformation b
structure is shown in the lower part of the figure. Domain and color codes
LRR: magenta.(Leu303-Leu313) (LLIFDGLDEAL), Sensor 1 (Thr345-
Arg347) (TSR), WH conserved histidine (His491) and
WH consensus sequence (Phe475-Ile480) (FYAKDI) based
on Proell et al. [4].
Modeling of the opened conformation of human
NLRC5 protein
Apoptosome is a molecular platform which mediates the
proteolytic processing of procaspases during apoptosis.
The apoptosome assembly is prompted by the activa-
tion of Apaf-1 protein by its conformational changes
and oligomerization [31]. As Apaf-1 heptamerizes in
the apoptosome complex, an opened conformation of
heptameric human NLRC5 was predicted by homology
modeling using the structure of the apoptosome-
procaspase-9 CARD complex [PDB: 3IYT] [31] as tem-
plate (see Additional file 2 and Additional file 3).
CARD domain of Apaf-1 seemed to be disordered in
the crystal structure of apoptosome-procaspase-9 CARD
complex [31]. Therefore, the uCARD domain of opened
conformational NLRC5 (Met1-Gly197) was built up using
the predicted structure of uCARD domain of closed con-
formational NLRC5.
The oligomerization is mediated by the NACHT
domain of NLRC5 (Asp198-Gly369) as in case of Apaf-1
[31]. Following construction of the heptameric NLRC55 protein. Top view (A) and side view (B) of the model of
y ribbon representation. Schematic representation of human NLRC5
: uCARD: cyan, NACHT: blue, AxP: green, WH: orange, SH: red,
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NACHT domains of the monomers and the uCARD
domains of the neighboring monomers, while overlap of
NACHT-NACHT or uCARD-uCARD domains of neigh-
boring monomers were not present. Therefore, the Val175.
n-Gln174.c-Gln174.ca-Gln174.n torsion angle was set from
155.1° to 90° within the uCARD-NACHT linker region
with which an opened conformation of monomeric NLRC5
was generated (Figure 4B). We predicted that this move-
ment of uCARD domain (Figure 4A and 4B) is needed for
the activation and allows the oligomerization of NLRC5.
Similar rearrangement of CARD domain was seen in case
of Apaf-1 protein during the activation and formation of
the heptamer [30].
Structure of the LRR domain of human NLRC5 was
predicted in this work based on the X-ray structure of
human RI protein as described above. This LRR domain
(Ile688-Thr1866) was joined to the opened conformational
NLRC5 (Met1-Ala652) by a linker region (Thr653-Gln687)Figure 6 Surface representation of monomeric full-length NLRC5. Top
NLRC5. Color codes: hydrophobic (yellow), amphipathic (dark yellow), polarlocated between the SH and LRR domains. Structure of the
SH domain was completed manually by using Sybyl
with the duplication of a four α-helix containing region
(Gln518-Lys606) of SH domain. This duplicated part
was merged into the structure as the continuation of
the α-helices of the SH domain (from Leu599) and also
served as a template to predict the structure of the lacking
SH-LRR linker region. The predicted structure of this
short region has a lower certainty, as it is expected to have
very high flexibility to facilitate the rearrangement of the
domains during the activation. The C-terminal end of the
Thr653-Gln687 region was close to the N-terminal end of
the LRR domain (Ile688-Thr1866) in its predicted spatial
position, therefore these terminal amino acids were
connected. A possible conformation of the SH-LRR linker
region (Thr653-Gln687) was optimized by a molecular
dynamics procedure. Molecular dynamics run on this linker
region was followed by short energy minimization of the
entire molecule without any fixed atoms to remove the(A), bottom (B) and side views (C) of modeled monomeric full-length
(orange), negatively charged (red), positively charged (brown).
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the monomeric full-length human NLRC5 is shown in
Figure 5. The structure was refined by a longer energy
minimization of the entire molecule and Sybyl program
was used to identify those atoms that potentially partici-
pate in hydrogen bond formation. Based on our model the
structure of monomeric NLRC5 is stabilized by LRR-GxP
and LRR-CARD interdomain interactions. We found
that in case of the investigated hydrogen bonds the
donor-acceptor distances became close to 3.0 Å during
the minimization like those being between the LRR circles.
These interacting residues of LRR domain are located in
the loop regions of the LRR motifs and can be found
mainly in the concave sides of the curved shape, near to
the inner side of the LRR helix. The hydrophobic residuesFigure 7 A model for heptameric full-length human NLRC5. Top (A) an
cyan, NACHT: blue, AxP: green, WH: orange, SH: red, LRR: magenta.of the LRRs can be found mainly in the core of these
structural motifs and the charged residues are mainly
exposed to the solvent (Figure 6).
It was described that the amino acid residues (Lys121-
Arg122-Arg132-Arg133-Lys134) forming the nuclear loca-
lization signal (NLS) of NLRC5 are located in the uCARD
domain [5]. In our model the NLS is exposed to the
solvent both in the opened and closed conformation,
but it is presumably less accessible in the opened con-
formation due to its proximity to the C-terminal end of
the LRR domain. Based on the predicted structure, the
NLS is not buried in the case of the closed conformational
state; therefore, the domain rearrangement during the acti-
vation does not appear to be necessary for the accessibility
of NLS.d side views (B) are represented. Domain and color codes: uCARD:
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tein (Figure 7) was built up from the opened conform-
ational NLRC5 monomers using the heptameric Apaf-1
protein as template structure. Domain architecture of
NLRC5 is similar to Apaf-1, which made the Apaf-1 a
useful template for homology modeling. It was described
that the oligomerization of these proteins depends on the
hydrolysis of a nucleotide triphosphate (e.g. ATP) which
leads to conformational changes, and the subsequent re-
arrangement of some domains is needed for the formation
of the oligomeric platform [4]. It was revealed previously
that most members of NOD-like receptor family share
the main structural and oligomerization properties with
Apaf-1 [4], therefore, we propose that activation leads
to the formation of a homo-heptamer of NLRC5.
In the model of full-length human NLRC5 the axes of
the heptameric platform and the LRR helices appear to
be parallel and the thickness of heptameric disc and the
height of LRR domains is very similar (Figure 7). In the
homo-heptameric NLRC5 there are large interacting
surfaces between the LRR and uCARD domains and
between the AxP and SH domains. The uCARD-NACHT
intramonomeric interactions of the closed conformational
monomeric protein can be broken during the activation
(as in case of Apaf-1 [31]), which can be compensated
by the development of NACHT-NACHT and uCARD-
LRR interactions during the assembly of the heptameric
platform.
In this work both the closed and opened conformational
states of full-length human NLRC5 protein were modeled
by homology modeling. Only short energy minimization
was performed on the opened conformational NLRC5
protein to study the intradomain interactions within the
full circles of LRR domain, and some interdomain interac-
tions within the monomeric NLRC5 protein. Although,
the study of the domain rearrangement of NLRC5 during
its activation was out of the scope of this study, we plan
to perform extended molecular dynamical calculations
in the future to study the motions of the NLRC5. Those
molecular dynamical calculations could help us evaluate
the development of the intermonomeric interactions
and the oligomer formation.
Our model presented here is in good agreement with
the previously proposed activation mechanism of NLR
proteins [32]. The NLRC5 undergoes conformational
changes during activation and an opened conform-
ational state is established from the closed conform-
ational (Figure 4A and 4B), allowing the formation of a
homo-heptameric structure (Figure 7). During the con-
formational change the NACHT domains which are
responsible for the oligomerization become exposed
due to the domain rearrangement and the uCARD
effector domains become accessible for the interacting
partner molecules.Conclusions
Although structures of several LRR-containing proteins
have been solved so far [10] the lack of crystal structures
of NLRs initiated several individual projects to model one
member of the family. There have been some approaches
that aimed to generate models for all members of the
family [4,8,12].
In our study presented here, homology modeling of
the full-length protein was completed by the sequence
alignment of NLRC5 and some NLRC5-related proteins
(NLRC1, NLRC2, NLRC3, RI and C2TA). We analyzed the
consensus patterns in the sequences of LRRs and rec-
ognized two typical consensus sequences in the LRRs
of NLRC5. However, NLRC5 has unusual N- and C-
terminal domains, therefore, it has not been modeled in
previous systematic studies and no homology model was
available for full-length human NLRC5 until now. In
the present study we provide a model for the full-length hu-
man NLRC5 in its closed conformation, furthermore, using
opened conformational monomers, a homo-heptameric
model was also built up.
NLRC5 is an intensively studied receptor with various
functions, including the capability of transcriptional regu-
lation of MHC class I, and its regulatory role in various
signal transduction pathways has also been reported.
NLRC5 has been reported to inhibit NFкB and type I
interferon signaling by binding to IKKα/β and retinoic
acid-inducible gene I (RIG-I)-like receptors, respectively.
It has been also shown that the LRR region of NLRC5
(Ala900-Arg1329) is responsible for mediating the inter-
action [33]. By modeling of NLRC5 structure, we may con-
tribute to the better understanding of potential interactions
of NLRC5 with other proteins, furthermore we may provide
molecular tools for future drug designs.
Our model can aid in better interpretation of NLRC5
structure studies in the future, identify structurally or
functionally critical residues of the molecule and may
assist in design of truncated forms of NLRC5 for further
understanding its functions.Additional files
Additional file 1: Result of secondary structure prediction performed
by using PredictProtein server. Predicted secondary structural
organization is indicated below the sequence of full-length NLRC5. α-helices
are indicated by "H" and β-sheets are indicated by "E". Predicted LRRs are
numbered and indicated by arrows below the sequence.
Additional file 2: Schematic representation of human NLRC5 and
the template structures used for homology modeling. Upper part:
Schematic representation of domain architecture of human NLRC5
protein. Lower part: Schematic representation of template structure parts
used for homology modeling of the opened and closed conformational
NLRC5 protein. Regions of Apaf-1 (1Z6T.pdb and 3IYT.pdb) and
ribonuclease inhibitor (1Z7T.pdb) proteins used for homology modeling
are indicated, together with the values of sequence identities between
the target and template sequences (%).
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http://www.biomedcentral.com/1471-2105/14/275Additional file 3: Sequences aligned for the homology modeling of
full-length human NLRC5 protein. Sequence of full-length NLRC5
protein is numbered (black). The homology modeling of N-terminal
domains of the closed conformational human NLRC5 protein was
performed based on the crystal structure of Apaf-1 protein [1Z6T.pdb]
(purple). With the exception of the uCARD domain, the N-terminal
domains of the opened conformational human NLRC5 were modeled
using the structure of the apoptosome-procaspase-9 CARD complex as
template [3IYT.pdb] (orange). The uCARD domain of opened
conformational NLRC5 was built up using the predicted structure of
uCARD domain of closed conformational NLRC5. The LRR domain of
human NLRC5 was predicted based on the X-ray structure of human
ribonuclease inhibitor [1Z7X.pdb] (blue, red and green). Some α-helices
of Apaf-1 protein were completed before homology modeling using the
Biopolymer module of Sybyl (brown). A possible conformation of the
SH-LRR linker region was optimized after homology modeling by a
molecular dynamics procedure using Sybyl (underlined). Identical (*) and
similar residues (":" and ".") are indicated, using the similarity defaults of
CLUSTAL X program.
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